The latest price target for CEL-SCI (AMEX:CVM) was reported by EF Hutton on July 12, 2023. The analyst firm set a price target for $10.00 expecting CVM to rise to within 12 months (a possible 784.96% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for CEL-SCI (AMEX:CVM) was provided by EF Hutton, and CEL-SCI reiterated their buy rating.

There is no last upgrade for CEL-SCI

There is no last downgrade for CEL-SCI.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CEL-SCI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CEL-SCI was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.

While ratings are subjective and will change, the latest CEL-SCI (CVM) rating was a reiterated with a price target of $0.00 to $10.00. The current price CEL-SCI (CVM) is trading at is $1.13, which is within the analyst’s predicted range.